Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy

被引：14

作者：

Sekhar R.V. ^{[1
]}

Jahoor F. ^{[1
]}

Pownall H.J. ^{[1
]}

Ballantyne C.M. ^{[1
]}

Balasubramanyam A. ^{[1
]}

机构：

[1] Division of Endocrinology, Baylor College of Medicine, Houston, TX 77030, One Baylor Plaza

来源：

Current Atherosclerosis Reports | 2004年 / 6卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Insulin Resistance; Cholesteryl Ester Transfer Protein; Lipodystrophy; Postprandial Lipemia; Intramyocellular Lipid;

D O I：

10.1007/s11883-004-0029-2

中图分类号：

学科分类号：

摘要：

The emergence of a new metabolic syndrome in patients with HIV infection, termed "HIV-associated dyslipidemic lipodystrophy" (HADL), is characterized by central fat redistribution, severe dyslipidemia, and insulin resistance and predisposes to an increased risk of cardiovascular disease. The factors promoting the development of cardiovascular disease in this condition are not well understood and may involve contributions from antiretroviral drugs and components of the HIV virus, as well as inflammatory cytokines, leading to accelerated lipolysis, dyslipidemia, lipotoxic insulin resistance, and vascular inflammation. In this article, we review HADL in terms of metabolic, molecular, and cytokine derangements leading to cardiovascular disease. Copyright © 2004 by Current Science Inc.

引用

页码：173 / 179

页数：6

共 50 条

[31] Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy
Hu, Miao
Tomlinson, Brian
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (10) : 1143 - 1150
[32] Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines
He, G
Andersen, O
Haugaard, SB
Lihn, AS
Pedersen, SB
Madsbad, S
Richelsen, B
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (09) : 583 - 590
[33] HIV-associated lipodystrophy in South Africa: The impact on the patient and the impact on the plastic surgeon
Zinn, Richard Joseph
Serrurier, Charles
Takuva, Simba
Sanne, Ian
Menezes, Colin Nigel
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2013, 66 (06) : 839 - 844
[34] Loss of subcutaneous adipose tissue in HIV-associated lipodystrophy is not due to accelerated apoptosis
Mynarcik, D
Wei, LX
Komaroff, E
Ferris, R
McNurlan, M
Gelato, M
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (01) : 53 - 56
[35] MRI of intra-abdominal fat and HIV-associated lipodystrophy: a case review
Carlier, R. Y.
de Truchis, P.
Ronze, S.
Mompoint, D.
Vaue, C.
Melchoir, J. C.
JOURNAL DE RADIOLOGIE, 2007, 88 (7-8): : 947 - 956
[36] Impact of inflammatory cytokine and adipokine gene variations in the development of HIV-associated lipodystrophy
Namdev, Goldi
Choudhari, Ranjana
Shyamveer, Abdul Arif
Khan, Abdul Arif
Ali, Nemat
Rashid, Summya
Singh, Hari Om
JOURNAL OF GENE MEDICINE, 2023, 25 (08)
[37] Soft tissue augmentation with PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy
Serra, Marcio Soares
Goncalves, Leonardo Zacharias
Ramos-e-Silva, Marcia
INTERNATIONAL JOURNAL OF STD & AIDS, 2015, 26 (04) : 279 - 284
[38] Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy
Mashiko, Takanobu
Tsukada, Kunihisa
Takada, Hitomi
Wu, Szu-Hsien
Kanayama, Koji
Asahi, Rintaro
Mori, Masanori
Kurisaki, Akira
Oka, Shinichi
Yoshimura, Kotaro
AIDS RESEARCH AND THERAPY, 2022, 19 (01)
[39] Investigation of SIRT1 gene variants in HIV-associated lipodystrophy and metabolic syndrome
da Silva Tagliari, Carmela Farias
de Oliveira, Caren Nunes
Vogel, Greice Meyer
da Silva, Patricia Baptista
Linden, Rafael
Lazzaretti, Rosmeri Kuhmmer
Notti, Regina Kuhmmer
Sprinz, Eduardo
Mattevi, Vanessa Sune
GENETICS AND MOLECULAR BIOLOGY, 2020, 43 (01)
[40] Clinical assessment of HIV-associated lipodystrophy syndrome: bioelectrical impedance analysis, anthropometry and clinical scores
Schwenk, A
Breuer, P
Kremer, G
Ward, L
CLINICAL NUTRITION, 2001, 20 (03) : 243 - 249

← 1 2 3 4 5 →